NATUREX : New acceleration in revenue confirmed at end-September 2010

le
0
Revenue - IFRS - in ¤ million
Pre-audit figures
2009
consolidated
2009
proforma
2010
consolidated
Proforma
growth
First quarter 27.5 48.1 51.6 + 7.3 %
Second quarter 26.9 47.7 60.5 + 26.7 %
Third quarter 22.9 44.9 58.5 + 30.2 %
9 months 77.3 140.7 170.6 + 21.2 %
Average US dollar exchange rate 1.3594 1.3594 1.3135  

2009 proforma revenues include the revenues generated by the Ingredients Division of Natraceutical Group which was consolidated as of January 1, 2010.

Avignon - 19 October 2010. Naturex's figures for the first nine months of 2010 are a tangible confirmation of the extremely dynamic activity and new scope that make it today's global leader in specialty plant-based natural ingredients.

At ¤ 58.5 million, group revenues for the third quarter were 2.6 times higher than the figure reported for the same period in 2009, amounting to an increase of 20.8% at constant scope and in constant currencies over the quarter.

Revenues for the first nine months of the year also grew 16.7% at constant scope and in constant currencies, coming in at ¤ 170.6 million compared to a figure of ¤ 77.3 million one year earlier.

Once again, each business and region contributed to the group's performance. Food & Beverage now accounts for 60.1% of group sales, Nutrition & Health for 33.4% and Personal Care for 1.2%. Europe and Africa account for 52.7% of group revenues, North and South America for 36.5 %, and the Asia/Pacific region for 10.8%.

Bolstered by this success, Naturex has confirmed the new targets for 2010 that were presented in September. Today, the group is aiming for sales growth of 10% to 15% at constant scope and in constant currencies (5% to 10% previously), and a 2.5 to 3 point increase in its operating margin on the proforma figure for 2009 (9% of revenue).

 

Naturex will publish its results for the third quarter of 2010 on Tuesday 9 November after the close of trading.

If you would like to receive financial information about Naturex by e-mail, go to: www.actusnews.com

NATUREX has been listed on segment B of Euronext Paris since October 1996.
Number of shares: 6,410,931 (4,884,298 ordinary shares and 1,526,633 preferential shares).
ISIN: FR0000054694 - Reuters: NATU.PA - Bloomberg: NRX:FP.
www.naturex.com

About Naturex:
Naturex is the global leader in specialty plant-based natural ingredients. The company produces and markets natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries. The group has three strategic divisions: Food & Beverage, Nutrition & Health and Personal Care.

Naturex's sound performance is linked to the fast-growing demand for natural ingredients and its capacity to provide manufacturers with the means to meet the requirements of their end consumers. Its strength lies in its ability to position itself on specific products which constitute niche markets.

Based in Avignon, the group employs around 900 people and realizes over 90% of its sales overseas. Naturex has production units across Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also has 15 sales offices located in Europe, the United States and Asia.

Naturex contacts: Actus contacts:
Jacques Dikansky
President and CEO
Tel. +33 (0)4 90 23 96 89
naturex@naturex.com

Thierry Lambert
Vice-President and CFO
Tel. +33 (0)4 90 23 96 89
t.lambert@naturex.com
Laurence Marquézy
Investor Relations
Tel. + 33 (0)1 72 74 82 23
lmarquezy@actus.fr

Anne Catherine Bonjour
Press Relations
Tel. + 33 (0)1 53 67 36 93
acbonjour@actus.fr

Annexes

Revenue - IFRS - in ¤ million
Pre-audit figures
Q1 2009
consolidated
Q1 2009
proforma
Q1 2010
consolidated
Europe/Africa 9.8 23.6 27.3
Americas 17.0 19.5 18.1
Asia/Pacific 0.7 5.0 6.3
Total 27.5 48.1 51.6
Q2 2009
consolidated
Q2 2009
proforma
Q2 2010
consolidated
Europe/Africa 9.8 23.9 32.9
Americas 16.3 18.4 22.4
Asia/Pacific 0.8 5.5 5.2
Total 26.9 47.7 60.5
Q3 2009
consolidated
Q3 2009
proforma
Q3 2010
consolidated
Europe/Africa 7.2 21.8 29.7
Americas 14.9 17.7 21.7
Asia/Pacific 0.8 5.4 7.1
Total 22.9 44.9 58.5
9M 2009
consolidated
9M 2009
proforma
9M 2010
consolidated
Europe/Africa 26.8 69.2 89.9
Americas 48.2 55.7 62.2
Asia/Pacific 2.3 15.8 18.5
Total 77.3 140.7 170.6
Revenue - IFRS - in ¤ million
Pre-audit figures
Q1 2009
consolidated
Q1 2009
proforma
Q1 2010
consolidated
Food & Beverage 7.9 27.9 30.3
Nutrition & Health 17.8 17.9 18.4
Personal Care 0.4 0.4 0.7
Miscellaneous (toll extraction) 1.4 1.9 2.2
Total 27.5 48.1 51.6
Q2 2009
consolidated
Q2 2009
proforma
Q2 2010
consolidated
Food & Beverage 7.9 28.4 36.4
Nutrition & Health 17.6 17.5 19.8
Personal Care 0.3 0.3 0.6
Miscellaneous (toll extraction) 1.2 1.5 3.7
Total 26.9 47.7 60.5
Q3 2009
consolidated
Q3 2009
proforma
Q3 2010
consolidated
Food & Beverage 7.2 28.6 35.9
Nutrition & Health 14.2 14.4 18.7
Personal Care 0.4 0.4 0.8
Miscellaneous (toll extraction) 1.1 1.5 3.2
Total 22.9 44.9 58.5
9M 2009
consolidated
9M 2009
proforma
9M 2010
consolidated
Food & Beverage 23.0 84.9 102.6
Nutrition & Health 49.6 49.8 56.9
Personal Care 1.0 1.0 2.0
Miscellaneous (toll extraction) 3.7 4.9 9.1
Total 77.3 140.7 170.6
Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-21484-cp-naturex-en-191010.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant